Bibliografia UJ CM

1/13
Holger N. Lode, Ruth Ladenstein, Sascha Troschke-Meurer, Linda Struppe, Nikolai Siebert, Maxi Zumpe, Karoline Ehlert, Stefanie Huber, Evgenia Glogova, Patrick Hundsdoerfer, Angelika Eggert, Anna Zaniewska-Tekieli, Walentyna Balwierz, Aleksandra Wieczorek.
Effect and tolerance of N5 and N6 chemotherapy cycles in combination with dinutuximab beta in relapsed high-risk neuroblastoma patients who failed at least one second-line therapy
Cancers
2023 : Vol. 15, nr 13, il., bibliogr. 39 poz., abstr., sum.
Autor korespondencyjny: Holger N. Lode
Open Access Creative Commons Attribution License CC-BY 4.0.
e-ISSN: 2072-6694
AZ
ORG
AIF
IF: 5.200
Adres url:
Streszczenie w PubMed:
2/13
Aleksandra Wieczorek, Carla Manzitti, Alberto Garaventa, Juliet Gray, Vassilios Papadakis, Dominique Valteau-Couanet, Katarzyna Zachwieja, Ulrike Poetschger, Ingrid Pribill, Stefan Fiedler, Ruth Ladenstein, Holger N. Lode.
Clinical phenotype and management of severe neurotoxicity observed in patients with neuroblastoma treated with dinutuximab beta in clinical trials.
Cancers
2022 : Vol. 14, nr 8, il., bibliogr. 33 poz., abstr., sum.
Autor korespondencyjny: Holger N. Lode.
Open Access Creative Commons Attribution License CC-BY 4.0.
e-ISSN: 2072-6694
AZ
ORG
AIF
IF: 5.200
Adres url:
Streszczenie w PubMed:
3/13
Angela Bellini, Ulrike Potschger, Virginie Bernard, Eve Lapouble, Sylvain Baulande, Peter F. Ambros, Nathalie Auger, Klaus Beiske, Marie Bernkopf, David R. Betts, Jaydutt Bhalshankar, Nick Bown, Katleen de Preter, Nathalie Clement, Valerie Combaret, Jaime Font de Mora, Sally L. George, Irene Jimenez, Marta Jeison, Barbara Marques, Tommy Martinsson, Katia Mazzocco, Martina Morini, Annick Muhlethaler-Mottet, Rosa Noguera, Gaelle Pierron, Maria Rossing, Sabine Taschner-Mandl, Nadine Van Roy, Ales Vicha, Louis Chesler, Walentyna Balwierz, Victoria Castel, Martin Elliott, Per Kogner, Genevieve Laureys, Roberto Luksch, Josef Malis, Maja Popovic-Beck, Shifra Ash, Olivier Delattre, Dominique Valteau-Couanet, Deborah A. Tweddle, Ruth Ladenstein, Gudrun Schleiermacher.
Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1).
Journal of Clinical Oncology
2021 : Vol. 39, nr 30, s. 3377-3390, il., bibliogr. 56 poz., abstr.
Autor korespondencyjny: Gudrun Schleiermacher.
Open Access Creative Commons Attribution License CC-BY 4.0.
p-ISSN: 0732-183X
e-ISSN: 1527-7755
AZ
ORG
AIF
IF: 50.739
Adres url:
Streszczenie w PubMed:
4/13
Daniel A. Morgenstern, Ulrike Potschger, Lucas Moreno, Vassilios Papadakis, Cormac Owens, Shifra Ash, Claudia Pasqualini, Roberto Luksch, Alberto Garaventa, Adela Canete, Martin Elliot, Aleksandra Wieczorek, Genevieve Laureys, Per Kogner, Josef Malis, Ellen Ruud, Maja Beck-Popovic, Gudrun Schleiermacher, Dominique Valteau-Couanet, Ruth Ladenstein.
Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN study.
Pediatric Blood & Cancer
2018 : Vol. 65, nr 11 art. no. e27363, s. 1-9, il., bibliogr. 34 poz., abstr.
Autor korespondencyjny: Ulrike Potschger.
p-ISSN: 1545-5009
AZ
ORG
AIF
IF: 2.486
Adres url:
Streszczenie w PubMed:
5/13
Ruth Ladenstein, Ulrike Pötschger, Andrew D.J. Pearson, Penelope Brock, Roberto Luksch, Victoria Castel, Isaac Yaniv, Vassilios Papadakis, Genevieve Laureys, Josef Malis, Walentyna Balwierz, Ellen Ruud, Per Kogner, Henrik Schroeder, Ana Forjaz De Lacerda, Maja Beck-Popovic, Pavel Bician, Miklós Garami, Toby Trahair, Adela Canete, Peter F. Ambros, Keith Holmes, Mark Gaze, Günter Schreier, Alberto Garaventa, Gilles Vassal, Jean Michon, Dominique Valteau-Couanet.
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial.
Lancet. Oncology
2017 : Vol. 18, nr 4, s. 500-514, il., bibliogr. 30 poz., sum.
Autor korespondencyjny: Ruth Ladenstein.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 36.418
Adres url:
Streszczenie w PubMed:
6/13
Ruth Ladenstein, Ulrike Poetschger, Martin Elliott, Roberto Luksch, Victoria Castel, Isaac Yaniv, Vassilios Papadakis, Genevieve Laureys, Josef Malis, Walentyna Balwierz, Ellen Ruud, Per Kogner, Henrik Schroeder, Ana Forjaz De Lacerda, Maja Beck Popovic, Pavel Bician, Miklos Garami, Toby Trahair, Andrew D.J. Pearson, Dominique Valteau Couanet.
Prognostic factors in stage 4 neuroblastoma treated with busulphan-melphalan: Report from the European HR-NBIA/Siopen trial.
Journal of Clinical Oncology
2016 : Vol. 34, nr 15 suppl., abstr. 10527.
2016 ASCO Annual Meeting, Chicago, 3-7 June 2016.
p-ISSN: 0732-183X
SZZ
SIF
7/13
Ruth Ladenstein, Ulrike Poetschger, Roberto Luksch, Penelope Brock, Victoria Castel, Isaac Yaniv, Vassilios Papadakis, Genevieve Laureys, Josef Malis, Walentyna Balwierz, Ellen Ruud, Per Kogner, Henrik Schroeder, Ana Forjaz De Lacerda, Maja Beck-Popovic, Pavel Bician, Miklos Garami, Toby Trahair, Peter Ambros, Andrew D.J. Pearson, Dominique Valteau-Couanet, SIOP Europe Neuroblastoma Group.
Major results from the HR-NBL1/SIOPEN trial for high risk neuroblastoma.
Pediatric Blood & Cancer
2012 : Vol. 59, nr 6, s. 988-989, abstr. O069
44th Congress of the International Society of Paediatric Oncology (SIOP), London, United Kingdom, 5th-8th October, 2012
p-ISSN: 1545-5009
SZZ
SIF
8/13
Klaus Beiske, Angela Sementa, Marta Jeison, Ales Vicha, Jerzy Klijanienko, Vassilios Papadakis, Yania Yanez, Aleksandra Wieczorek, Ariane Boubaker, Milada Cvancarova, Ulrike Potschger, Ruth Ladenstein, Katrien Swerts.
Quantification of bone marrow disease in high risk neuroblastoma patients with anti-GD2 immunocytochemistry at diagnosis and at end of induction therapy - impact on event-free and overall survival. A SIOPEN high risk study.
Pediatric Blood & Cancer
2012 : Vol. 59, nr 6, s. 996, abstr. O097
44th Congress of the International Society of Paediatric Oncology (SIOP), London, United Kingdom, 5th-8th October, 2012
p-ISSN: 1545-5009
SZZ
SIF
9/13
Ruth Ladenstein, Ulrike Poetschger, Roberto Luksch, Penelope Brock, Victoria Castel, Isaac Yaniv, Vassilios Papadakis, Genevieve Laureys, Josef Malis, Walentyna Balwierz, Ellen Ruud, Per Kogner, Henrik Schroeder, Ana Forjaz De Lacerda, Maja Beck-Popovic, Pavel Bician, Miklos Garami, Toby Trahair, Andrew D.J. Pearson, Dominique Valteau-Couanet.
Busulphan-melphalan is the superior myeloablative therapy (MAT) for high-risk neuroblastoma: Results from the HR-NBL1/SIOPEN Trial.
Pediatric Blood & Cancer
2011 : Vol. 57, nr 5, s. 733, abstr. O103
43rd Congress of the International Society of Pediatric Oncology (SIOP) 2011, Auckland, New Zealand, 28th-30th October, 2011
p-ISSN: 1545-5009
SZZ
SIF
10/13
Maja Beck-Popovic, Emma Garcia, Nicole Gross, Valerine Combaret, Peter Ambros, Klaus Beiske, Alessandro Jenkner, Anne-Sophie Defachelles, Adela Canete, Benedicte Brichard, Walentyna Balwierz, Vassilios Papadakis, Shifra Ash, Ellen Ruud, Ruth Ladenstein, Ingrid Ora, Keith Holmes, Bruno De Bernardi, Jean Michon, Veronique Mosseri.
Characteristics of relapsing localized neuroblastoma : A prelimnary report of the second SIOPEN study (LNESG2, localized neuroblastoma European study group 2).
W: Advances in Neuroblastoma Research ANR 2010, Stockholm, Sweden, 21-24 June : programme and abstract book
s. 124 : abstr. OR60.
SZZ
AWZ
11/13
Ruth Ladenstein, Dominique Valteau-Couanet, Penelope Brock, Isaac Yaniv, Victoria Castel, Genevieve Laureys, Josef Malis, Vassilios Papadakis, Ana Lacerda, Ellen Ruud, Per Kogner, Miklos Garami, Walentyna Balwierz, Henrik Schroeder, Maja Beck-Popovic, Gunter Schreier, David Machin, Ulrike Potschger, Andrew Pearson.
Randomized Trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma : the European HR-NBL1/SIOPEN study.
Journal of Clinical Oncology
2010 : Vol. 28, nr 21, s. 3516-3524, il., bibliogr. 55 poz.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 18.970
12/13
Katrien Swerts, Peter Ambros, Marta Jeison, Ales Vicha, Walentyna Balwierz, Jose Maria Fernandez Navarro, Nicole Gross, Jerzy Klijanienko, Aleksandra Niezgoda, Angela Sementa, Ruth Ladenstein, Klaus Beiske.
Extensive validation of a standardized immunocytochemical technique for minimal residual disease detection in neuroblastoma : A Siopen Bone Marrow Subcommittee Study.
W: 40th Congress of the International Society of Paediatric Oncology, Berlin, Germany, October 2-6, 2008 : abstract book
s. 92-93 : abstr. A048.
SZZ
AWZ
13/13
Katrien Swerts, Peter F. Ambros, Marta Jeison, Ales Vicha, Walentyna Balwierz, Jose Maria Fernandez Navarro, Nicole Gross, Jerzy Klijanienko, Aleksandra Niezgoda, Angela Sementa, Ruth Ladenstein, Klaus Beiske.
Extensive Validation of the standardized immunocytochemical technique for detection of disseminated neuroblastoma cells : a SIOPEN Bone Marrow Subcommittee Study.
W: Advances in Neuroblastoma Research : International Conference Hall Chiba, Japan, May 21-24, 2008 : program & abstracts
s. 154 : abstr. TR67.
SZZ
AWZ
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ